Joshua Barocas, MD is an Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center. . He received his medical degree from the George Washington University School of Medicine and Public Health. He completed his Internal Medicine residency and was subsequently Chief Resident at the University of Wisconsin Hospitals and Clinics. Dr. Barocas completed a fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA.
He leads an an interdisciplinary research program that is specifically aimed at the goal of improving health outcomes for patients with infectious diseases including HIV and HCV, substance use disorders, and other vulnerable populations. His research, which uses clinical epidemiology, health economics, simulation modeling, and cost-effectiveness, informs clinical-decision making and health policy to answer clinically- and policy-relevant questions. He is engaged in research using these innovative methods to help understand the impact of and improve upon policies that affect people who use drugs infected with or at high risk for HIV and viral hepatitis. His research has been funded by NIDA, NIAID, the Providence/Boston Center for AIDS Research (CFAR), the BU-CTSI, and the MGH Executive Committee on Research Fund for Medical Discovery. He currently serves as Director of the Health Economics and Modeling Core for the Massachusetts HEALing Communities Study, an NIH-funded grant to significantly reduce overdose. He has been the recipient of several research awards including a NIDA Career Development Award (K01), the Charles A. King Trust Research Award, and the prestigious AAMC Herbert W. Nickens Faculty Fellowship Award, which recognizes a junior faculty member who demonstrates leadership potential in addressing inequity in health care. He has published over 30 peer-reviewed articles and editorials, including in leading journals such as NEJM, JAMA Internal Medicine, AJPH, Addiction, Clinical Infectious Diseases, and Annals of Internal Medicine. His work has been widely cited in the media, including the Boston Globe, U.S. News and World Report, and NPR.
- George Washington University School of Medicine, MD
- Washington University in St. Louis, BA
- Published on 6/9/2020
Barocas JA, Blackstone E, Bouton TC, Kimmel SD, Caputo A, Porter SJ, Walley AY. Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA. J Addict Med. 2020 Jun 09. PMID: 32530889.
- Published on 3/12/2020
Barocas JA. It's not them, it's us: Hepatitis C reinfection following successful treatment among people who inject drugs. Clin Infect Dis. 2020 Mar 12. PMID: 32166311.
- Published on 3/2/2020
Rosenberg ES, Barocas JA. USPSTF's Hepatitis C Screening Recommendation-A Necessary Step to Tackling an Evolving Epidemic. JAMA Netw Open. 2020 Mar 02; 3(3):e200538. PMID: 32119098.
- Published on 2/14/2020
Serota DP, Barocas JA, Springer SA. Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases. Clin Infect Dis. 2020 Feb 14; 70(5):968-972. PMID: 31420651.
- Published on 1/30/2020
Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP. Opioid overdose and inpatient care for substance use disorder care in Massachusetts. J Subst Abuse Treat. 2020 May; 112:42-48. PMID: 32199545.
- Published on 1/22/2020
Merchant E, Burke D, Shaw L, Tookes H, Patil D, Barocas JA, Wurcel AG. Hospitalization outcomes of people who use drugs: One size does not fit all. J Subst Abuse Treat. 2020 May; 112:23-28. PMID: 32199542.
- Published on 1/21/2020
Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes Associated with Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis. Clin Infect Dis. 2020 Jan 21. PMID: 31960025.
- Published on 7/19/2019
Barocas JA. Commentary on Irvine et al. (2019): Barriers to implementing a successful roadmap for preventing opioid-related overdose deaths. Addiction. 2019 09; 114(9):1614-1615. PMID: 31321824.
- Published on 6/27/2019
Barocas JA, So-Armah K, Cheng DM, Lioznov D, Baum M, Gallagher K, Fuster D, Gnatienko N, Krupitsky E, Freiberg MS, Samet JH. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia. PLoS One. 2019; 14(6):e0218852. PMID: 31246992.
- Published on 5/10/2019
Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 10; 72:160-168. PMID: 31085063.
View 21 more publications: View full profile at BUMC